Richmond Brothers’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.15M | Buy |
554,469
+9,568
| +2% | +$19.8K | 0.75% | 21 |
|
|
2025
Q1 | $1.2M | Sell |
544,901
-97,438
| -15% | -$214K | 0.76% | 20 |
|
|
2024
Q4 | $983K | Buy |
642,339
+131,557
| +26% | +$201K | 0.63% | 22 |
|
|
2024
Q3 | $1.02M | Buy |
510,782
+154,224
| +43% | +$307K | 0.63% | 24 |
|
|
2024
Q2 | $1.25M | Buy |
356,558
+59,852
| +20% | +$209K | 2.47% | 8 |
|
|
2024
Q1 | $822K | Hold |
296,706
| – | – | 1.52% | 10 |
|
|
2023
Q4 | $504K | Buy |
296,706
+193,697
| +188% | +$329K | 0.88% | 13 |
|
|
2023
Q3 | $106K | Buy |
103,009
+60,604
| +143% | +$62.4K | 0.2% | 23 |
|
|
2023
Q2 | $49.2K | Buy |
+42,405
| New | +$49.2K | 0.08% | 22 |
|